Oncolytic Bioweapon: Engineered Bacteria to Deploy Viruses that Attack Cancer Cells
CAPPSID – an engineered partnership between bacteria and an oncolytic virus,...
CAPPSID – an engineered partnership between bacteria and an oncolytic virus,...
Green light from MHRA for Krazati (Adagrasib) – that targets NSCLC....
AstraZeneca's new drug – Sipavibart, represents a significant step forward in...
As reports of turmeric-induced liver injury surface, a deeper understanding of...